Inventor
FIORUCCI STEFANO
IT16 patents
⚠️ This page may combine multiple inventors who share the name “FIORUCCI STEFANO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INTERCEPT PHARMACEUTICALS INC
5 patentsUS9763964B2Sep 19, 2017
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
INTERCEPT PHARMACEUTICALS INC23 citations93
US7932244B2Apr 26, 2011
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
INTERCEPT PHARMACEUTICALS INC24 citations92
US7858608B2Dec 28, 2010
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
INTERCEPT PHARMACEUTICALS INC21 citations92
US10987362B2Apr 27, 2021
Treatment of fibrosis using FXR ligands
INTERCEPT PHARMACEUTICALS INC0 citations62
US9090652B2Jul 28, 2015
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
INTERCEPT PHARMACEUTICALS INC3 citations62
ANTIBE THERAPEUTICS INC
3 patentsUS7910568B2Mar 22, 2011
Derivatives of 4- or 5-aminosalicylic acid
ANTIBE THERAPEUTICS INC55 citations95
US7498355B2Mar 3, 2009
Derivatives of 4- or 5-aminosalicylic acid
ANTIBE THERAPEUTICS INC6 citations71
US7879827B2Feb 1, 2011
Derivatives of 4- or 5-aminosalicylic acid
ANTIBE THERAPEUTICS INC0 citations50
FIORUCCI STEFANO
2 patentsBAR PHARMACEUTICALS S R L
2 patentsUS10407462B2Sep 10, 2019
Cholane derivatives for use in the treatment and/or prevention of FXR and TGR5/GPBAR1 mediated diseases
BAR PHARMACEUTICALS S R L7 citations76
US11117926B2Sep 14, 2021
Cholane derivatives for use in the treatment and/or prevention of FXR and TGR5/GPBAR1 mediated diseases
BAR PHARMACEUTICALS S R L0 citations55